GSK3B and myotonic dystrophy type 1: To examine if the increase in active GSK3β in CDM1 blood is not due to age differences in control and CDM1 patients, the levels of active GSK3β were compared in unrelated control blood samples of pediatric patients not affected by DM1 and CDM1 patients.